News

The collaboration will focus on the development and implementation of continuous process technologies from research to full-scale production. The purpose of the project is to study the utilization

During the term of the agreement, the retailer will have the exclusive rights to distribute Derma Sciences’s Medihoney antimicrobial products at retail throughout Canada. The $2 million per

Under the secured loan agreement, Somaxon borrowed $15 million from the lenders. The loan is secured by a first priority security interest in all of the company’s assets,

Animal reproductive toxicity studies recently completed with RDEA806 have demonstrated no effects on male or female fertility or on early embryonic development at all tested doses. These results

The interim results of this Phase I/II study of targeted gene delivery in vivo are very encouraging – intravenous infusions of Rexin-G demonstrated significant biological activity without toxicity

This patent adds to the intellectual property surrounding Aveo’s proprietary and cancer biology platform. Tuan Ha-Ngoc, president and CEO of Aveo, said: “We are very pleased to receive

STEMPRO mesenchymal stem cells (MSC) serum free media (SFM) is a first of its kind product that overcomes many challenges in MSC culture. In addition to launching Stempro

As a result of the agreement, a team of Stanford graduate students will be working to extend Tibion’s technology platform to additional medical applications. The work will serve

Seahorse extracellular flux (XF) analyzers provide method to non-invasively measure the two major energy producing pathways – mitochondrial respiration and glycolysis – in living cells. The microplate-based technology